Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis

Published:2024-03-11 Issue:7 Volume:20 Page:793-801
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Huang Jinge¹^ORCID,Zhu Qingmiao²,Wang Baizhou¹,Wang Hanzheng¹,Xie Zhijun²,Zhu Xingyu³,Zhao Ting²,Yang Zi⁴⁵

Affiliation:

1. The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China

2. School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China

3. Department of Nephrology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China

4. The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China

5. Teaching Faculty, New Zealand College of Chinese Medicine, Greenlane, New Zealand

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

General Scientific Research Project of Zhejiang Education Department

Zhejiang Provincial Administration of Chinese Medicine

Scientific Research Projects of Zhejiang Chinese Medical University

Science Youth Exploration Project of Zhejiang Chinese Medical University

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2024.2324005

Reference75 articles.

1. Systemic Lupus Erythematosus

2. Predictors of Pregnancy Outcomes in Patients With Lupus

3. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases

4. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

5. Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?